Apoptotic effect of cleaved high molecular weight kininogen is regulated by extracellular matrix proteins
- 25 April 2003
- journal article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 89 (3) , 622-632
- https://doi.org/10.1002/jcb.10536
Abstract
We previously reported that cleaved high molecular weight kininogen (HKa) and its domain 5 (D5) inhibit critical steps required for angiogenesis and in vivo neovascularization (Colman et al. 2000: Blood 95:543–550). We have further shown that D5 is able to induce apoptosis of endothelial cells, which may represent a critical part of the anti‐angiogenic activity of HKa and D5 (Guo et al. 2001: Arterioscler Thromb Vasc Biol 21:1427–1433). In this study, we demonstrate that HKa‐ and D5‐induced apoptosis is closely correlated with their anti‐adhesive effect. An important new finding is that the apoptotic activity of HKa and D5 is highly regulated by their interactions with different extracellular matrix (ECM) proteins. HKa inhibited cell adhesion to vitronectin (Vn, 90%) and gelatin (Gel) (40%), but it had no apparent effect on cell adhesion to fibronectin (Fn). D5 showed a similar pattern on cell adhesion but was less potent than HKa. HKa induced apoptosis of endothelial cells grown on Vn and Gel but not cells grown on Fn which closely parallels with its anti‐adhesive potency. Further results revealed that the anti‐adhesive effect and the apoptotic effect of HKa are associated with its ability to inhibit phosphorylation of focal adhesion kinase (FAK) and paxillin, two important signal molecules required for cell adhesion and cell viability. We conclude that the anti‐adhesive activity of HKa and D5 is responsible for their apoptotic effect and that Vn is likely an ECM component that mediates the effect of HKa and D5.Keywords
This publication has 46 references indexed in Scilit:
- Inhibition of FAK signaling activated by urokinase receptor induces dormancy in human carcinoma cells in vivoOncogene, 2002
- Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor–dependent interactionsBlood, 2000
- Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesisBlood, 2000
- The Hemostatic System as a Regulator of AngiogenesisPublished by Elsevier ,2000
- Factors Promoting Tumor AngiogenesisCancer Investigation, 1999
- Biologic Activities of the Contact Factors In VivoThrombosis and Haemostasis, 1999
- Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migrationCurrent Opinion in Cell Biology, 1997
- Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.Journal of Clinical Investigation, 1997
- Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell GrowthJournal of Biological Chemistry, 1997
- Inhibition of cell adhesion by high molecular weight kininogen.The Journal of cell biology, 1992